HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshio Kase Selected Research

shakuyaku-kanzoh-toh

11/2015Pharmacokinetic Profiles of Active Components After Oral Administration of a Kampo Medicine, Shakuyakukanzoto, to Healthy Adult Japanese Volunteers.
1/2013Antispasmodic effect of shakuyakukanzoto extract on experimental muscle cramps in vivo: role of the active constituents of Glycyrrhizae radix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshio Kase Research Topics

Disease

9Sleep Initiation and Maintenance Disorders (Insomnia)
01/2017 - 09/2009
6Hot Flashes
01/2011 - 11/2003
5Inflammation (Inflammations)
01/2017 - 02/2008
5Pain (Aches)
01/2017 - 12/2006
5Neoplasms (Cancer)
01/2017 - 02/2014
5Dementia (Dementias)
05/2015 - 10/2009
4Peripheral Nervous System Diseases (PNS Diseases)
11/2016 - 01/2012
4Hyperalgesia
11/2016 - 12/2006
4Nephritis
02/2011 - 03/2006
3Body Weight (Weight, Body)
01/2017 - 03/2007
3Cachexia
01/2017 - 02/2014
3Stomatitis
06/2016 - 01/2015
3Hypersensitivity (Allergy)
06/2016 - 12/2002
2Anorexia
01/2017 - 02/2014
2Oral Ulcer (Mouth Ulcer)
01/2017 - 06/2016
2Cold Hypersensitivity
11/2016 - 01/2014
2Muscle Cramp (Cramp)
11/2015 - 01/2013
2Acne Vulgaris
09/2015 - 01/2015
2Skin Diseases (Skin Disease)
09/2015 - 01/2015
2Atherosclerosis
01/2013 - 05/2008
2Insulin Resistance
06/2012 - 05/2008
2Leiomyoma (Uterine Fibroids)
06/2012 - 08/2011
2Atopic Dermatitis (Atopic Eczema)
11/2011 - 10/2009
2Learning Disabilities (Learning Disability)
04/2011 - 10/2010
2Thiamine Deficiency
10/2010 - 01/2010
2Alzheimer Disease (Alzheimer's Disease)
06/2009 - 02/2009
2Ischemia
09/2006 - 03/2002
2Prostatic Neoplasms (Prostate Cancer)
11/2004 - 11/2003
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2018
1Mucositis
01/2017
1Human Influenza (Influenza)
01/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2017
1Ulcer
06/2016
1Dyskinesias (Dyskinesia)
01/2016
1Knee Osteoarthritis
12/2015
1Arthralgia (Joint Pain)
12/2015
1Hydrarthrosis
12/2015
1Hyperesthesia
11/2015
1Atrophy
11/2015
1Paresthesia (Dysesthesia)
11/2015
1Hypesthesia (Numbness)
11/2015
1Abdominal Pain (Pain, Abdominal)
11/2015

Drug/Important Bio-Agent (IBA)

17Yi-Gan SanIBA
01/2016 - 02/2009
6CytokinesIBA
01/2013 - 08/2006
5Calcitonin Gene-Related PeptideIBA
06/2007 - 03/2002
4liu-jun-zi-tangIBA
01/2017 - 12/2013
4Pharmaceutical PreparationsIBA
01/2017 - 07/2005
4Estrogens (Estrogen)FDA Link
04/2013 - 03/2005
4Hormones (Hormone)IBA
06/2012 - 11/2003
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2012 - 03/2005
4Proteins (Proteins, Gene)FDA Link
04/2011 - 01/2008
3Analgesics (Analgesic Drugs)IBA
01/2017 - 06/2016
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2016 - 01/2014
3gosha-jinki-ganIBA
11/2016 - 01/2014
3Indomethacin (Indometacin)FDA LinkGeneric
06/2016 - 03/2007
3keishibukuryoganIBA
04/2016 - 03/2005
3ChemokinesIBA
01/2013 - 06/2009
3sairei-toIBA
01/2008 - 03/2006
3ginger extractIBA
07/2005 - 03/2002
215- methyl- 8- aza- 16- oxagona- 1,3,5(10),13- tetraen- 17- one (MAOTO)IBA
01/2017 - 01/2017
2shogaolIBA
01/2017 - 03/2002
2shakuyaku-kanzoh-tohIBA
11/2015 - 01/2013
2jumi-haidoku-toIBA
09/2015 - 01/2015
2AndrogensIBA
01/2015 - 11/2004
2Testosterone (Sustanon)FDA Link
01/2015 - 11/2004
2Glutamic Acid (Glutamate)FDA Link
01/2014 - 01/2010
2Interleukin-8 (Interleukin 8)IBA
01/2011 - 06/2008
2Glycyrrhetinic Acid (Po 12)IBA
01/2010 - 04/2007
2Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2010 - 04/2007
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2009 - 12/2006
2Formaldehyde (Formol)FDA Link
05/2009 - 12/2006
2GABA-A Receptors (GABA(A) Receptor)IBA
05/2009 - 12/2006
2Estradiol (Delestrogen)FDA LinkGeneric
05/2008 - 11/2004
2antiglomerular basement membrane antibodyIBA
01/2008 - 03/2006
2Histamine (Histamine Dihydrochloride)FDA Link
06/2007 - 12/2002
2calcitonin gene-related peptide (8-37)IBA
06/2007 - 03/2002
2ProgesteroneFDA LinkGeneric
07/2005 - 11/2004
2Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
11/2003 - 03/2002
1SaponinsIBA
01/2017
1GhrelinIBA
01/2017
1EphedrineFDA LinkGeneric
01/2017
1gingerolIBA
01/2017
1Toll-Like Receptor 3IBA
01/2017
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2016
1bushiIBA
11/2016
1methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA
06/2016
1Acetic Acid (Vinegar)FDA LinkGeneric
06/2016
1PowdersIBA
04/2016
1BenserazideIBA
01/2016
1Levodopa (L Dopa)FDA LinkGeneric
01/2016
1boiogitoIBA
12/2015
1AntioxidantsIBA
09/2015

Therapy/Procedure

14Kampo Medicine (Kampo)
01/2018 - 12/2002
5Therapeutics
01/2017 - 11/2004
5Oral Administration
04/2016 - 07/2005
2Radiotherapy
07/2015 - 01/2015
1Analgesia
01/2017
1Chemoradiotherapy
06/2016